Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02065089 · ClinicalTrials.gov registry record · NA
Development of 'Emma'--a Pediatric IBD Quiz
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT02065089: Completed NA study, sponsored by Mayo Clinic.
NCT02065089 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02065089, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
We would like to collaborate and further develop an ipad-based, interactive quiz game 'Emma'; to identify gaps in knowledge of inflammatory bowel disease in pediatric patients. These gaps can be used to improve patient education.
Primary Outcome
The patient will play the ipad quiz game at office visits over time. We will look for improvements in overall knowledge of IBD, as well as subcategories (ex. nutrition, medications, etc.)
Interventions
- OTHER playing the ipad quiz game
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2014-02-06 |
| Est. Completion | 2017-01-05 |
| Phase | NA |
What the finished NCT02065089 record still lists
NCT02065089 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which playing the ipad quiz game is the first listed.
NCT02065089 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02065089 about?
NCT02065089 is a clinical study titled "Development of 'Emma'--a Pediatric IBD Quiz". We would like to collaborate and further develop an ipad-based, interactive quiz game 'Emma'; to identify gaps in knowledge of inflammatory bowel disease in pediatric patients. These gaps can be used to improve patient education.
What is the current status of trial NCT02065089?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2014-02-06. Estimated completion is 2017-01-05.
What interventions are being tested in trial NCT02065089?
The interventions under investigation include: playing the ipad quiz game (OTHER).
Who is sponsoring clinical trial NCT02065089?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02065089's enrollment target sits among peer trials
116 808th of 2000 higher than 1,191 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI